Display options
Cite
Dasari S, Ali SM, Zheng G, et al. Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget. 2017;8(34):57782-57799doi: 10.18632/oncotarget.17997.
Dasari, S., Ali, S. M., Zheng, G., Chen, A., Dontaraju, V. S., Bosland, M. C., Kajdacsy-Balla, A., & Munirathinam, G. (2017). Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget, 8(34), 57782-57799. https://doi.org/10.18632/oncotarget.17997
Dasari, Subramanyam, et al. "Vitamin K and its analogs: Potential avenues for prostate cancer management." Oncotarget vol. 8,34 (2017): 57782-57799. doi: https://doi.org/10.18632/oncotarget.17997
Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, Kajdacsy-Balla A, Munirathinam G. Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget. 2017 May 19;8(34):57782-57799. doi: 10.18632/oncotarget.17997. eCollection 2017 Aug 22. PMID: 28915711; PMCID: PMC5593683.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 May 19;8(34):57782-57799. doi: 10.18632/oncotarget.17997. eCollection 2017 Aug 22.

Vitamin K and its analogs: Potential avenues for prostate cancer management.

Oncotarget

Subramanyam Dasari, Syed M Ali, Guoxing Zheng, Aoshuang Chen, Venkata Satish Dontaraju, Maarten C Bosland, Andre Kajdacsy-Balla, Gnanasekar Munirathinam

Affiliations

  1. Department of Biomedical Sciences, College of Medicine, University of Illinois, Rockford, IL, USA.
  2. Internal Medicine, Rockford Memorial Hospital, Rockford, IL, USA.
  3. Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.

PMID: 28915711 PMCID: PMC5593683 DOI: 10.18632/oncotarget.17997

Abstract

Epidemiological studies have demonstrated a relationship between cancer incidence and dietary habits. Especially intake of certain essential nutrients like vitamins has been shown to be beneficial in experimental studies and some clinical trials. Vitamin K (VK) is an essential nutrient involved in the blood clotting cascade, and there are considerable experimental data demonstrating its potential anticancer activity in several cancer types including prostate cancer. Previous

Keywords: Vitamin K; apoptosis and autophagy; dietary constituents; prostate cancer

Conflict of interest statement

CONFLICTS OF INTEREST Authors declare that they do not have conflicts of interest.

References

  1. Mutat Res. 2004 Nov 2;555(1-2):53-64 - PubMed
  2. Prostate. 1994 Jun;24(6):299-305 - PubMed
  3. Mol Med Rep. 2012 Jan;5(1):126-32 - PubMed
  4. Curr Cancer Drug Targets. 2004 Feb;4(1):13-28 - PubMed
  5. Hepatology. 2004 Jul;40(1):243-51 - PubMed
  6. Jpn J Clin Oncol. 2003 Sep;33(9):421-42 - PubMed
  7. Eur J Cancer. 2010 Sep;46(14):2555-62 - PubMed
  8. Arch Ital Urol Androl. 2003 Sep;75(3):127-34 - PubMed
  9. Cancer Res. 2007 Sep 1;67(17):8164-71 - PubMed
  10. Nutrients. 2016 Sep 09;8(9): - PubMed
  11. PLoS One. 2013;8(3):e58082 - PubMed
  12. Mol Pharmacol. 2007 Jul;72(1):29-39 - PubMed
  13. J Thromb Haemost. 2003 Aug;1(8):1730-3 - PubMed
  14. J Cancer Res Clin Oncol. 2008 Jul;134(7):803-12 - PubMed
  15. Br J Radiol. 1997 Jun;70(834):599-602 - PubMed
  16. Clin Immunol. 2001 Dec;101(3):335-44 - PubMed
  17. Am J Clin Nutr. 2010 May;91(5):1348-58 - PubMed
  18. Oncogene. 2005 Jun 30;24(28):4486-95 - PubMed
  19. J Biol Chem. 1999 Jan 8;274(2):987-92 - PubMed
  20. Cancer Res. 2000 Mar 1;60(5):1317-25 - PubMed
  21. Leukemia. 2001 Jul;15(7):1111-7 - PubMed
  22. Int J Cancer. 2003 Jan 20;103(3):285-93 - PubMed
  23. Cancer Chemother Pharmacol. 1995;36(4):293-8 - PubMed
  24. Urol Oncol. 2016 Nov;34(11):483.e1-483.e8 - PubMed
  25. Arch Biochem Biophys. 1986 Aug 1;248(2):460-6 - PubMed
  26. Nutr Cancer. 2015;67(7):1104-12 - PubMed
  27. Exp Biol Med (Maywood). 2004 Apr;229(4):277-84 - PubMed
  28. J Neurochem. 2002 Aug;82(3):538-49 - PubMed
  29. J Biol Chem. 1992 Feb 5;267(4):2474-9 - PubMed
  30. Asian J Androl. 2013 May;15(3):309-13 - PubMed
  31. Mol Cell Biochem. 2004 Nov;266(1-2):37-56 - PubMed
  32. Ann N Y Acad Sci. 2002 Jun;963:148-55 - PubMed
  33. CA Cancer J Clin. 2005 May-Jun;55(3):178-94 - PubMed
  34. Nat Rev Cancer. 2002 Jul;2(7):537-43 - PubMed
  35. Biochem Mol Biol Int. 1997 Jan;41(1):93-101 - PubMed
  36. Int J Oncol. 2007 Aug;31(2):323-31 - PubMed
  37. Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):129-43 - PubMed
  38. Anticancer Res. 2008 Sep-Oct;28(5A):2727-32 - PubMed
  39. J Endourol. 2013 Dec;27(12):1499-503 - PubMed
  40. Food Chem Toxicol. 2003 Oct;41(10):1399-407 - PubMed
  41. Ann N Y Acad Sci. 2001 Dec;952:145-52 - PubMed
  42. J Nutr. 2001 Jan;131(1):158S-160S - PubMed
  43. Clinics (Sao Paulo). 2012 Sep;67(9):1093-9 - PubMed
  44. Cancer Biochem Biophys. 1998 Jun;16(1-2):17-30 - PubMed
  45. Cell. 1992 Apr 3;69(1):119-28 - PubMed
  46. Mol Cancer Ther. 2011 Sep;10(9):1533-41 - PubMed
  47. Int J Cancer. 2005 Mar 1;113(6):1010-4 - PubMed
  48. Int J Biol Sci. 2014 Sep 13;10(9):1072-83 - PubMed
  49. Nature. 1947 Jul 19;159(4055):98 - PubMed
  50. Cancer Chemother Pharmacol. 2013 Jun;71(6):1629-34 - PubMed
  51. BMC Gastroenterol. 2012 Nov 29;12:170 - PubMed
  52. Drug Des Devel Ther. 2015 Mar 12;9:1511-54 - PubMed
  53. Cancer Metastasis Rev. 2002;21(3-4):217-30 - PubMed
  54. J Histochem Cytochem. 2001 Jan;49(1):109-20 - PubMed
  55. Eur Urol. 1999;35(5-6):342-50 - PubMed
  56. Cancer Res. 2006 Jun 1;66(11):5828-35 - PubMed
  57. J Biol Chem. 1995 Nov 24;270(47):28304-10 - PubMed
  58. Nat Rev Cancer. 2003 Oct;3(10):768-80 - PubMed
  59. J Biol Chem. 1996 Jun 28;271(26):15420-7 - PubMed
  60. Biol Pharm Bull. 2012;35(1):10-7 - PubMed
  61. Hepatology. 1995 Sep;22(3):876-82 - PubMed
  62. J Natl Cancer Inst. 2006 Feb 15;98(4):245-54 - PubMed
  63. Pharmacol Ther. 2013 Dec;140(3):223-38 - PubMed
  64. J Natl Cancer Inst. 2003 Nov 5;95(21):1578-86 - PubMed
  65. Cancer Control. 2002 May-Jun;9(3):236-43 - PubMed
  66. EMBO Rep. 2006 Feb;7(2):180-5 - PubMed
  67. Curr Opin Drug Discov Devel. 2009 Mar;12(2):240-5 - PubMed
  68. Cancer Prev Res (Phila). 2015 May;8(5):375-86 - PubMed
  69. Oncol Lett. 2012 Jul;4(1):163-167 - PubMed
  70. Ultrastruct Pathol. 2014 Apr;38(2):116-40 - PubMed
  71. Gynecol Oncol. 2007 Dec;107(3):450-7 - PubMed
  72. Curr Urol Rep. 2016 Apr;17(4):35 - PubMed
  73. Am J Clin Nutr. 2008 Apr;87(4):985-92 - PubMed
  74. Anticancer Res. 2001 Jul-Aug;21(4A):2387-92 - PubMed
  75. Nat Med. 2002 Mar;8(3):216-8 - PubMed
  76. Anticancer Drugs. 2012 Apr;23(4):437-44 - PubMed
  77. Oncogene. 2014 May 29;33(22):2815-25 - PubMed
  78. Free Radic Res. 1997 Jun;26(6):585-92 - PubMed
  79. J Cell Biochem. 2004 Feb 1;91(2):232-42 - PubMed
  80. Free Radic Biol Med. 1997;23(6):844-50 - PubMed
  81. JAMA. 1998 Jan 28;279(4):300-7 - PubMed
  82. Int J Oncol. 2011 Mar;38(3):603-11 - PubMed
  83. Vitam Horm. 2008;78:211-26 - PubMed
  84. Int Urol Nephrol. 2002;34(2):207-14 - PubMed
  85. Mol Cell Biol. 1998 Sep;18(9):5414-24 - PubMed
  86. Clin Nutr. 2016 Nov 24;:null - PubMed
  87. Prostate. 1999 Feb 15;38(3):228-36 - PubMed
  88. PLoS One. 2012;7(9):e45023 - PubMed
  89. Nutr Cancer. 2016;68(1):1-17 - PubMed
  90. Free Radic Biol Med. 2010 Dec 1;49(11):1603-16 - PubMed
  91. Oncol Rep. 2004 Mar;11(3):681-5 - PubMed
  92. J Gastroenterol Hepatol. 2010 Apr;25(4):738-44 - PubMed
  93. Toxicol Appl Pharmacol. 2013 Dec 15;273(3):611-22 - PubMed
  94. Curr Pharmacol Rep. 2015 Aug 1;1(4):258-265 - PubMed
  95. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):549-52 - PubMed
  96. Hepatol Res. 2007 Sep;37 Suppl 2:S303-7 - PubMed
  97. Endocrinology. 2003 Jan;144(1):50-60 - PubMed
  98. Int J Clin Exp Med. 2015 Aug 15;8(8):14432-9 - PubMed
  99. J Natl Cancer Inst. 2014 Mar;106(3):djt456 - PubMed
  100. Integr Cancer Ther. 2002 Jun;1(2):121-32; discussion 132 - PubMed
  101. Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302 - PubMed
  102. N Engl J Med. 2000 Jun 29;342(26):1953-8 - PubMed
  103. Mol Carcinog. 2004 Feb;39(2):114-26 - PubMed
  104. Ann Oncol. 2013 Sep;24(9):2402-8 - PubMed
  105. Altern Med Rev. 2003 Aug;8(3):303-18 - PubMed
  106. Cancer Res. 2007 Jul 1;67(13):6293-303 - PubMed
  107. Int J Mol Med. 2006 Feb;17(2):235-43 - PubMed
  108. Cancer Lett. 2016 Feb 1;371(1):71-8 - PubMed
  109. J Natl Cancer Inst. 2005 Jan 19;97(2):94-102 - PubMed
  110. Eur J Cancer. 1999 Sep;35(9):1388-93 - PubMed
  111. Pharmacol Res. 2016 Mar;105:134-45 - PubMed
  112. Science. 1997 Nov 14;278(5341):1305-9 - PubMed
  113. Surg Oncol. 2002 Jun;11(1-2):3-11 - PubMed
  114. Nutr J. 2004 Oct 20;3:19 - PubMed
  115. J Biol Chem. 1997 Nov 7;272(45):28191-3 - PubMed
  116. JAMA. 2011 Oct 12;306(14):1549-56 - PubMed
  117. Evid Based Complement Alternat Med. 2013;2013:287358 - PubMed
  118. Oncogene. 2004 Apr 12;23(16):2850-60 - PubMed
  119. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1596-610 - PubMed
  120. Int J Cancer. 2013 Jun 1;132(11):2606-12 - PubMed
  121. Drug Discov Today. 2007 Feb;12(3-4):112-24 - PubMed
  122. Curr Cancer Drug Targets. 2004 Feb;4(1):1-11 - PubMed
  123. Exp Cell Res. 1999 May 25;249(1):109-15 - PubMed
  124. World J Surg Oncol. 2012 Apr 21;10:60 - PubMed
  125. Mol Cancer Ther. 2002 Nov;1(13):1161-72 - PubMed
  126. Biol Pharm Bull. 2012;35(4):617-23 - PubMed
  127. Korean J Hepatobiliary Pancreat Surg. 2015 Feb;19(1):1-5 - PubMed
  128. Eur J Med Chem. 2003 May;38(5):451-7 - PubMed
  129. Nat Rev Cancer. 2009 Jul;9(7):501-7 - PubMed
  130. Br J Cancer. 2010 Apr 13;102(8):1224-34 - PubMed
  131. Cancer Biol Ther. 2008 Dec;7(12):1875-84 - PubMed
  132. Chem Biol Interact. 2015 Oct 5;240:120-33 - PubMed
  133. J Hepatol. 2002 Jan;36(1):85-92 - PubMed
  134. J Nutr. 2002 Oct;132(10):3191-4 - PubMed
  135. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):378-82 - PubMed
  136. Br J Cancer. 2014 Feb 18;110(4):899-907 - PubMed
  137. ScientificWorldJournal. 2013 May 27;2013:379641 - PubMed
  138. Int J Cancer. 2009 Apr 1;124(7):1693-9 - PubMed
  139. Int J Oncol. 2005 Jan;26(1):33-40 - PubMed
  140. Am J Clin Nutr. 2003 Sep;78(3 Suppl):559S-569S - PubMed
  141. Autophagy. 2008 Jul;4(5):629-40 - PubMed
  142. Asian J Surg. 2010 Jul;33(3):120-6 - PubMed
  143. Nutr Cancer. 2005;53(1):18-32 - PubMed
  144. Toxicol Pathol. 2007 Jun;35(4):495-516 - PubMed
  145. Mol Pharmacol. 2013 Mar;83(3):613-20 - PubMed
  146. Cancer Prev Res (Phila). 2014 Nov;7(11):1081-107 - PubMed
  147. Cell. 2011 Nov 11;147(4):742-58 - PubMed
  148. Thromb Haemost. 2004 Apr;91(4):801-5 - PubMed
  149. Evid Based Complement Alternat Med. 2012;2012:957568 - PubMed
  150. J Urol. 2004 Feb;171(2 Pt 2):S30-4; discussion S35 - PubMed
  151. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):654-8 - PubMed
  152. Biochem Biophys Res Commun. 2004 Jan 9;313(2):453-8 - PubMed
  153. Nutr Cancer. 1998;32(3):123-31 - PubMed
  154. Indian J Exp Biol. 1998 Sep;36(9):891-5 - PubMed
  155. JAMA. 2009 Jan 7;301(1):39-51 - PubMed
  156. Asian Pac J Cancer Prev. 2013;14(9):5461-5 - PubMed
  157. Mol Cancer Ther. 2006 Dec;5(12):3209-21 - PubMed
  158. Clin Immunol. 1999 Oct;93(1):65-74 - PubMed
  159. PLoS One. 2012;7(12):e52263 - PubMed
  160. Int J Mol Med. 2007 Dec;20(6):801-8 - PubMed
  161. Curr Opin Urol. 2006 May;16(3):168-72 - PubMed
  162. Gynecol Oncol. 2007 Apr;105(1):23-30 - PubMed
  163. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):49-56 - PubMed
  164. Cell Death Differ. 2000 Dec;7(12):1166-73 - PubMed
  165. Neoplasia. 2003 May-Jun;5(3):255-66 - PubMed
  166. Mol Cancer Ther. 2012 Feb;11(2):416-26 - PubMed
  167. Clin Chim Acta. 2003 Apr;330(1-2):57-83 - PubMed
  168. Cancer Cell. 2006 Sep;10(3):175-6 - PubMed
  169. J Gastroenterol. 2009;44(3):228-35 - PubMed
  170. Eur J Cancer. 2001 May;37(8):948-65 - PubMed
  171. Annu Rev Nutr. 1992;12:37-57 - PubMed
  172. Biomed Res Int. 2015;2015:121826 - PubMed
  173. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):340-5 - PubMed
  174. Ultrastruct Pathol. 2010 May;34(3):140-60 - PubMed

Publication Types

Grant support